The role of Shenqi Fuzheng injection as adjuvant therapy for breast cancer: an overview of systematic reviews and meta-analyses
Abstract Background Breast cancer (BC) is the most frequent malignancy in the world. Chemotherapy (CT) is a common treatment for BC but is accompanied by toxicity and side effects. Shenqi Fuzheng Injection (SFI) is an adjuvant therapy with promising results in improving efficacy and reducing toxicit...
| Príomhchruthaitheoirí: | , , , , , , |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
BMC
2024-01-01
|
| Sraith: | BMC Complementary Medicine and Therapies |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1186/s12906-023-04274-4 |